Document and Entity Information
Document and Entity Information | Mar. 03, 2023 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001610618 |
Document Type | 8-K |
Document Period End Date | Mar. 03, 2023 |
Entity Registrant Name | Cidara Therapeutics, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-36912 |
Entity Tax Identification Number | 46-1537286 |
Entity Address, Address Line One | 6310 Nancy Ridge Drive |
Entity Address, Address Line Two | Suite 101 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92121 |
City Area Code | 858 |
Local Phone Number | 752-6170 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, Par Value $0.0001 Per Share |
Trading Symbol | CDTX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |